Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?

To: Jack Stirling who wrote (110)	3/31/1998 8:04:00 AM
From: lazarre	Read Replies (1) \| Respond to of 642

Jack: I'm not such a smart guy but this is what I sense: 1) LLY is taking a hit because the reality of Evista sales have not met it's expectations. If you're long, the jury is still in deliberations, and you'll be ok. Acceptance and sales will come,IMO. 2)LLY is still reverberating from last weeks downgrade by an analyst. 3) Once the $60 support level was broken it shook loose some recent buyers who either took some profits from the low and mid 60's or who just got spooked. We may see more southerly movementBUT great oppt'y to buy. By end of April, LLY back in mid 60's, IMO. Maybe more if Asia comes here to roost.